Boryung Biopharma to enter basic vaccine business.

Published: 2005-05-30 06:58:00

Updated: 2005-05-30 06:58:00

Boryung Biopharma made an exclusive distribution agreement with SIIL (Serum Institute of India Ltd), a leading Indian drug company, initially distributing 2 vaccines of SIIL, measle/rubeola and diphtheria/tetanus, which were recognized by WHO and predominated in the world markets.

Boryung Biop...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK